Narcotic analgesic combination drugs are medicines that contain an opiate pain reliever, with at least one different analgesic such as acetaminophen or ibuprofen. These should be utilized to treat direct to extreme pain when other less intense analgesics are not effective. Narcotic analgesics (also called sedatives, opioid analgesics, or opiates) ease intense and chronic extreme pain by binding to opioid receptors. The three types of opioid receptors are mu, delta, and kappa. Most opiate analgesics combination bind to the narcotic “mu” receptor and are extremely effective in relieving pain. However, these also initiate remunerate pathways implying that narcotic analgesic combination tends to cause dependence and addiction (where expanding doses are expected to give a similar pain-relieving effect). Diverse opiate pain relieving mixes have distinctive potencies and reactions in view of the ingredients these contain.
Rise in prevalence of osteoarthritis, back pain, and rheumatoid arthritis are the major factors propelling the global narcotic analgesic combination drugs market. Increase in incidence of overactive bladder also drives the narcotic analgesic combination drugs market. However, side effects of drugs such as constipation, vomiting, loss of appetite, and urination problem, and death due to overdose of narcotic analgesic combination drugs are factors likely to restrain the market in the next few years.
Based on indication, the global narcotic analgesic combination drugs market can be segmented into chronic cough, osteoarthritis, rheumatoid arthritis, and others. The osteoarthritis segment is likely to expand at a rapid pace during the forecast period. This can be attributed to rise in geriatric population with osteoarthritis. In terms of drug class, the global Narcotic Analgesic Combination Drugs market can be categorized into opiate agonists, analgesics, and others. The analgesics segment is likely to expand at a rapid pace during the forecast period, attributed to high preference by doctors to relieve pain, as it has low side effects and help prevent blood clots in elderly patients. Based on route of administration, the global narcotic analgesic combination drugs market can be classified into oral, intravenous, and intramuscular. The oral segment is likely to expand at a rapid pace during the forecast period. Oral administration is the most frequently preferred route by doctors because of its simplicity and convenience. Moreover, the degree of bioavailability of oral dose form of narcotic analgesic combination drugs is high and for this reason it quickly absorbed in the blood, only a tract amount remain in the gastrointestinal tract.
In terms of region, the global narcotic analgesic combination drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Growth of the narcotic analgesic combination drugs market in North America is attributed to favorable reimbursement policies for prescription drugs. Rise in geriatric population with osteoarthritis pain and availability of wide range of over-the-counter drugs for pain management are likely to propel the narcotic analgesic combination drugs market in Europe. Increase in geriatric population and rising awareness among the health professionals to address different diseases and infection through various combination drugs are anticipated to drive the market in Asia Pacific. Rise in prevalence of neuropathic pain, arthritic pain, and chronic back pain in Africa is expected to propel the narcotic analgesic combination drugs market in Middle East & Africa during the forecast period.
Key players operating in the global narcotic analgesic combination drugs market are BioDelivery Sciences International, Inc., Pfizer Inc., Allergan plc, Teva Pharmaceuticals, Akron, Inc., UCB, Inc., and Endo Pharmaceuticals, Inc., among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.